The Centre for Solar Biotechnology is fast tracking next generation solar factories based on microalgae to produce a wide range of products including recombinant protein biologics, anti-virals, anti-bacterials, novel biopharmaceuticals, pigments, proteins, nanomaterials and anti-oxidants.

Objective/mission (The vision): To develop detailed and comprehensive production models to transform research findings into commercial viability.

Research approach (The initiative): The use of parallel analysis of financial, energy and GHG emissions results through our unique TELCA (techno-economic and life cycle assessment) model to determine and optimise the viability of algae-based production pathways for the generation of pharmaceuticals, nutritional products, animal feeds and renewable fuels.

Impacts and applications: As the world moves to more sustainable production it is essential that new products and production systems are assessed for energy and GHG impacts as well as traditional financial assessment. The parallel assessment and optimisation of these parameters ensures the long-term viability of potential industries.

Project members

Key contacts

Professor Ben Hankamer

Director, IMB Centre for Solar Biotechnology
Professorial Research Fellow - GL
Institute for Molecular Bioscience

Mr John Roles

Research Fellow
Institute for Molecular Bioscience